2023 - Ludlow Research

MetAlert (MLRT) Purchase Order with Gun Range for Firearms Tracking Platform

October 10, 2023Ludlow Research

(NEW YORK)–The recent news from MetAlert (OTC: MLRT) presents a bullish opportunity for investors. MetAlert’s acquisition of Level 2 Security and first commercial order of the GunAlert firearm recovery device come at an opportune time. The gun safety market is rapidly expanding. The Office of Justice Programs just committed an unprecedented $100 million for community […]

Fear Indicator Points to Potential Xmas Rally in Stocks

October 4, 2023December 23, 2023Ludlow Research

Buy Signal: Fear Index Hits Extreme High Fear & Greed is best used as a contrarian indicator. In the words of General George S. Patton, “If everyone is thinking alike, then somebody isn’t thinking.” The fact that CNN’s Fear & Greed Indicator is at an extreme greed level and is at the lowest level of […]

MetAlert (MLRT) Signs Deal to Offer AI Health Assistant, Highlighting Growing Demand

July 13, 2023July 13, 2023Ludlow Research

(NEW YORK)–MetAlert, Inc. (OTC: MLRT) recently announced an agreement to offer HandsFree Health’s WellBe digital health tool, an AI-powered virtual health assistant. This highlights the growing demand for AI assistants in healthcare and the potential for companies like MetAlert to capitalize on this trend. WellBe is a voice-enabled assistant that uses artificial intelligence to track […]

Ludlow Research Launches Sector Focus on OTC Healthcare Issuers

April 26, 2023June 25, 2023Ludlow Research

(NEW YORK)–Ludlow Research, an equity research firm located in New York City, announced upcoming research focus on the small-cap Healthcare and Medical Device sector. Inflation, rising interest rates, falling consumer confidence, stress within banking sector all signal the possibility for a recession if not softer economy in 2023. While no investment is completely recession-proof, healthcare […]

Titan Lithium (CDSG) Issued Bullish Outlook Based on Lithium Test Results at Tanzania Project

March 29, 2023June 25, 2023Ludlow Research

(NEW YORK)–Ludlow Research alerted its subscribers on March 28, 2023 that it had initiated a research opinion on Titan Lithium (OTC:CDSG) based on strong test results from their Tanzania Lithium mine, and our continued bullish outlook for the Lithium sector. In late Feb. 2023, the company signed a Definitive Agreement with Kilimanjaro Lithium, whereby CDSG […]

Q BioMed (QBIO) Issued Bullish Valuation Outlook on Liver Cancer Drug

February 16, 2023June 25, 2023Ludlow Research

(NEW YORK)–Ludlow Research issued research alert to its subscribers on Q BioMed Inc. (OTCQB: QBIO), a biotech acceleration and commercial stage company focused on licensing and acquiring undervalued biomedical assets in the healthcare sector, with $0.10+ price target based on current market cap valuation, and potential for its Liver cancer drug patent. On Feb. 10, […]

MetAlert (MLRT) Analyst Brief

January 5, 2023June 25, 2023Ludlow Research

MetAlert, Inc. (OTC: MLRT) is a pioneer in smart, mobile, and wearable tracking and recovery location-based solutions, supported through a proprietary iot enterprise monitoring platform and intellectual property portfolio. The Company offers a global end-to-end solution of hardware, software and connectivity and develops two-way GPS tracking technologies, which seamlessly integrate with consumer products and enterprise […]